Dr Amy Chung is a Laboratory Head at the Department of Microbiology and Immunology, University of Melbourne at the Doherty Institute. Her research focuses upon the application of cutting-edge experimental technologies to holistically examine functional antibodies against a range of infectious diseases including HIV. This research can be used to design future antibody-based vaccines and can contribute to the generation of improved monoclonal antibody therapeutics.

Prof. David Lynn is Head of the Systems Immunology Laboratory at SAHMRI; Scientific Director of SA Genomics Centre; and Professor at Flinders University. His research investigates how microbes (pathogenic and commensal) modulate the immune system in a range of contexts from infection (including COVID-19) to immunisation and immunotherapy.

Hyon-Xhi Tan is an NHMRC Fellow at the Viral Vax Lab (viralvaxlab.com), Doherty Institute, focusing on anti-viral humoral immunity against influenza and human coronaviruses. His research has detailed mechanisms driving B cell recognition of viral antigens, developed novel vaccine strategies to enhance neutralising antibodies and established insights underpinning lung immunity.

Mee Ling Munier is a Research Fellow at the Kirby Institute, UNSW Sydney. Her group utilises fine needle biopsies (FNB) / fine needle aspirates (FNA) to study immune responses to vaccination within human lymph nodes. To characterise the cellular responses, high dimensional flowcytometry and single cell RNA-sequencing methods are employed.

Associate Professor Smith heads the Translational and Human Immunology laboratory at QIMR Berghofer Medical Research Institute. His work focuses upon T-cell mediated control of infection and cancer and the application of this knowledge to develop T cell immunotherapies. His work has been translated into multiple clinical trials in head and neck cancer, brain cancer, organ transplant recipients, multiple sclerosis and COVID-19.